Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1532642

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1532642

Weight Loss and Obesity Management Market Size - Product and Services (Supplement, Drug [GLP-1 Receptor Agonist, Lipase Inhibitor, Serotonin Receptor Agonist], Equipment [Fitness Monitoring, Surgical], Service), Age Group & Global Forecast, 2024 - 2032

PUBLISHED:
PAGES: 86 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Weight Loss and Obesity Management Market will register over 8.6% CAGR over 2024 and 2032, driven by the heightened awareness of the health risks linked to obesity, such as diabetes, cardiovascular issues, and hypertension. According to the World Health Organization (WHO), over 650 million adults were obese in 2022, underscoring the urgency for effective interventions. Concurrently, a surge in sedentary lifestyles and poor dietary habits is amplifying obesity rates. The availability of diverse weight loss programs, dietary supplements, and fitness equipment, catering to individuals striving for effective weight management and better health will favor the market outlook.

Technological strides, like minimally invasive surgeries and innovative fitness devices, are bolstering industry share. There is increasing adoption of digital health platforms and mobile apps for personalized weight management and real-time tracking. For instance, a report by the American Heart Association highlighted that digital health interventions could reduce body weight by an average of 3.5%. The government initiatives worldwide, aimed at curbing obesity rates and promoting healthier living, will push the demand.

The overall weight loss and obesity management market is classified based on product & services, age group, and region.

The equipment segment is witnessing significant traction due to the rising awareness of the importance of physical activity in maintaining a healthy weight. As more individuals adopt fitness-centric lifestyles, there is a preference for home-based exercise equipment, driven by convenience and accessibility. Additionally, advancements in fitness technology, such as smart exercise machines and wearable devices that offer real-time tracking and personalized workout plans, are making these products more appealing to consumers seeking effective and engaging ways to manage their weight.

The children segment is poised to display significant growth over the forecast period, owing to the rising prevalence of childhood obesity, which has become a major public health concern globally. Increasing awareness among parents and educators about the long-term health risks associated with obesity in children is driving demand for specialized weight management programs and products tailored to younger age groups. Furthermore, government initiatives and school-based programs aimed at promoting physical activity and healthy eating habits among children are expected to bolster the segment growth.

Europe weight loss and obesity management industry will register strong CAGR through 2032, driven by the increasing prevalence of obesity, especially among children. This rise in obesity rates is linked to sedentary lifestyles, unhealthy eating habits, and increased consumption of high-calorie foods. Additionally, there is a growing awareness and adoption of weight management programs and surgical interventions, which are further supported by government initiatives aimed at promoting healthier lifestyles. The rising popularity of natural and organic weight management supplements also contributes to the industry growth, as consumers seek safer and more effective solutions for weight loss

Product Code: 9706

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of obesity and overweight
      • 3.2.1.2 Growing approval for obesity treatment drugs
      • 3.2.1.3 Increasing awareness towards fitness activities
      • 3.2.1.4 Growing demand for bariatric surgery to treat extreme obesity
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Increasing incidence of adverse events
      • 3.2.2.2 Lack of standardization in nutraceuticals
  • 3.3 Growth potential analysis
  • 3.4 Future market trends
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product & Services, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Supplements
  • 5.3 Drugs
    • 5.3.1 GLP-1 receptor agonists
    • 5.3.2 Lipase inhibitors
    • 5.3.3 Combination drugs
    • 5.3.4 Serotonin receptor agonists
    • 5.3.5 Other drugs
  • 5.4 Equipment
    • 5.4.1 Fitness equipment
    • 5.4.2 Fitness monitoring equipment
    • 5.4.3 Surgical equipment
    • 5.4.4 Other equipment
  • 5.5 Services

Chapter 6 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Adult
  • 6.3 Children

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
    • 7.3.7 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Rest of Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

  • 8.1 Allurion
  • 8.2 Amgen Inc.
  • 8.3 Boehringer Ingelheim International GmbH
  • 8.4 Eisai Co., Ltd.
  • 8.5 Equinox Inc.
  • 8.6 FOUND
  • 8.7 Herbalife International of America, Inc.
  • 8.8 Johnson & Johnson Services Inc. (Ethicon Inc.)
  • 8.9 Kellogg Co.
  • 8.10 Lifetime Fitness Inc.
  • 8.11 Medtronic plc
  • 8.12 Novo Nordisk A/S
  • 8.13 Nutrisystem, Inc.
  • 8.14 OptiBiotix Online
  • 8.15 PRISTYN CARE
  • 8.16 Roman Health Ventures Inc.
  • 8.17 Takeda Pharmaceutical Company Ltd.
  • 8.18 Teleflex Inc.
  • 8.19 VIVUS LLC.
  • 8.20 WW International, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!